79 related articles for article (PubMed ID: 24174637)
1. Analysis of the roles of mutations in thyroid hormone receptor-β by a bacterial biosensor system.
Shi C; Meng Q; Wood DW
J Mol Endocrinol; 2014 Feb; 52(1):55-66. PubMed ID: 24174637
[TBL] [Abstract][Full Text] [Related]
2. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
[TBL] [Abstract][Full Text] [Related]
3. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.
Maraninchi M; Bourcigaux N; Dace A; El-Yazidi C; Malezet-Desmoulins C; Krempf M; Torresani J; Margotat A
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):569-76. PubMed ID: 17177139
[TBL] [Abstract][Full Text] [Related]
5. Development of a thyroid hormone receptor targeting conjugate.
Zheng J; Hashimoto A; Putnam M; Miller K; Koh JT
Bioconjug Chem; 2008 Jun; 19(6):1227-34. PubMed ID: 18507428
[TBL] [Abstract][Full Text] [Related]
6. The oligomeric state of thyroid receptor regulates hormone binding kinetics.
Cunha Lima ST; Rodrigues ED
J Endocrinol; 2011 Jul; 210(1):125-34. PubMed ID: 21508093
[TBL] [Abstract][Full Text] [Related]
7. Ligand induced interaction of thyroid hormone receptor beta with its coregulators.
Valadares NF; Polikarpov I; Garratt RC
J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):205-12. PubMed ID: 19000767
[TBL] [Abstract][Full Text] [Related]
8. Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone.
Shi Y; Ye H; Link KH; Putnam MC; Hubner I; Dowdell S; Koh JT
Biochemistry; 2005 Mar; 44(12):4612-26. PubMed ID: 15779888
[TBL] [Abstract][Full Text] [Related]
9. 3,5-T2 is an alternative ligand for the thyroid hormone receptor β1.
Mendoza A; Navarrete-Ramírez P; Hernández-Puga G; Villalobos P; Holzer G; Renaud JP; Laudet V; Orozco A
Endocrinology; 2013 Aug; 154(8):2948-58. PubMed ID: 23736295
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of complementing ligands for mutant thyroid hormone receptor TRbeta(R320H): a tailor-made approach toward the treatment of resistance to thyroid hormone.
Hashimoto A; Shi Y; Drake K; Koh JT
Bioorg Med Chem; 2005 Jun; 13(11):3627-39. PubMed ID: 15862991
[TBL] [Abstract][Full Text] [Related]
11. Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor beta.
Garcia Collazo AM; Koehler KF; Garg N; Färnegårdh M; Husman B; Ye L; Ljunggren J; Mellström K; Sandberg J; Grynfarb M; Ahola H; Malm J
Bioorg Med Chem Lett; 2006 Mar; 16(5):1240-4. PubMed ID: 16338239
[TBL] [Abstract][Full Text] [Related]
12. Selective chemical rescue of a thyroid-hormone-receptor mutant, TRbeta(H435Y), identified in pituitary carcinoma and resistance to thyroid hormone.
Hassan AQ; Koh JT
Angew Chem Int Ed Engl; 2008; 47(38):7280-3. PubMed ID: 18683837
[No Abstract] [Full Text] [Related]
13. Biochemical characterization of four novel mutations in the thyroid hormone receptor beta gene in patients with resistance to thyroid hormone.
Asadi AB; Torjesen PA; Haug E; Berg JP
Scand J Clin Lab Invest; 2008; 68(7):563-7. PubMed ID: 19378427
[TBL] [Abstract][Full Text] [Related]
14. In silico modelling of prostacyclin and other lipid mediators to nuclear receptors reveal novel thyroid hormone receptor antagonist properties.
Perez Diaz N; Zloh M; Patel P; Mackenzie LS
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():18-27. PubMed ID: 26686607
[TBL] [Abstract][Full Text] [Related]
15. Establishment of transactivation assay systems using fish, amphibian, reptilian and human thyroid hormone receptors.
Oka T; Mitsui-Watanabe N; Tatarazako N; Onishi Y; Katsu Y; Miyagawa S; Ogino Y; Yatsu R; Kohno S; Takase M; Kawashima Y; Ohta Y; Aoki Y; Guillette LJ; Iguchi T
J Appl Toxicol; 2013 Sep; 33(9):991-1000. PubMed ID: 23112079
[TBL] [Abstract][Full Text] [Related]
16. On the denaturation mechanisms of the ligand binding domain of thyroid hormone receptors.
Martínez L; Souza PC; Garcia W; Batista FA; Portugal RV; Nascimento AS; Nakahira M; Lima LM; Polikarpov I; Skaf MS
J Phys Chem B; 2010 Jan; 114(3):1529-40. PubMed ID: 20043653
[TBL] [Abstract][Full Text] [Related]
17. Complete activation of thyroid hormone receptor β by T3 is essential for normal cochlear function and morphology in mice.
Richter CP; Münscher A; Machado DS; Wondisford FE; Ortiga-Carvalho TM
Cell Physiol Biochem; 2011; 28(5):997-1008. PubMed ID: 22178950
[TBL] [Abstract][Full Text] [Related]
18. Identification of the putative MAP kinase docking site in the thyroid hormone receptor-beta1 DNA-binding domain: functional consequences of mutations at the docking site.
Lin HY; Zhang S; West BL; Tang HY; Passaretti T; Davis FB; Davis PJ
Biochemistry; 2003 Jun; 42(24):7571-9. PubMed ID: 12809513
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance.
Cheng SY
Trends Endocrinol Metab; 2005; 16(4):176-82. PubMed ID: 15860414
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation (M310L) in the thyroid hormone receptor beta causing resistance to thyroid hormone in a Brazilian kindred and a neonate.
Furlanetto TW; Kopp P; Peccin S; Gu WX; Jameson JL
Mol Genet Metab; 2000 Nov; 71(3):520-6. PubMed ID: 11073720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
